Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study

The ARON-3 project collects data for patients with prostate cancer treated in multiple centers worldwide to assess outcomes in the real-world setting. We analyzed data for patients with metastatic hormone-sensitive prostate cancer receiving apalutamide. Our results show that apalutamide is a safe and effective drug in the real-world setting as well as in clinical trials.

Authors

Institutions

Publication Details

Journal
European Urology Oncology
Published
2024-11-29
DOI
https://doi.org/10.1016/j.euo.2024.11.005
Citations
11
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
4.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study

Tarek Taha, Ondřej Fiala, Zin Myint, Pasquale Rescigno et al.
11 citations
European Urology Oncology
Prostate Cancer Treatment and Research
4.61
article

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study

Tarek Taha, Ondřej Fiala, Zin Myint, Pasquale Rescigno, Sebastiano Buti, Camillo Porta, Rossana Berardi, Matteo Santoni, E Thomas Pierce, Thomas Büttner, Orazio Caffo, Michal Uher, Luca Galli, Carlo Messina, Renato Bisonni, Andrey Soares, Veronica Mollica, Giandomenico Roviello, Ray Kopp Manneh, Nicola Battelli, Mimma Rizzo, Aristotelis Bamias, Luigi Formisano, Marc Matrana, Franco Morelli, Nicolò Cavasin, Lorena Incorvaia, Francesco Massari, Gaetano Aurilio, Gaetano Facchini, Alexandr Poprach, Fernando Sabino Marques Monteiro, Sarah Scagliarini, Francesca Zacchi, Francesco Grillone, Xue Jiang, Umberto Basso, Roubini Zakopoulou, Jawaher Ansari, Daniele Santini, Jiří Navrátil, Alessandro Rizzo, Fernando Cotait Maluf, Gianpaolo Spinelli, R. Chandler, Fabio Calabrò
article en
11 citations

Abstract

The ARON-3 project collects data for patients with prostate cancer treated in multiple centers worldwide to assess outcomes in the real-world setting. We analyzed data for patients with metastatic hormone-sensitive prostate cancer receiving apalutamide. Our results show that apalutamide is a safe and effective drug in the real-world setting as well as in clinical trials.

European Urology OncologyVol. 8(2)
University of Verona (IT), University of Parma (IT), Royal Marsden NHS Foundation Trust (GB), National and Kapodistrian University of Athens (GR), Charles University (CZ), University Hospital Bonn (DE), Ochsner Medical Center (US), Casa Sollievo della Sofferenza (IT), Hospital Israelita Albert Einstein (BR), Policlinico Umberto I (IT), Freeman Hospital (GB), Markey Cancer Center (US), Popular University of Cesar (CO), Eastern Cooperative Oncology Group (US), Tawam Hospital (AE), Ospedale Santa Chiara (IT), Veterinary Oncological Center (IT), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Istituto Oncologico Veneto (IT), Beneficência Portuguesa de São Paulo (BR), Masaryk Memorial Cancer Institute (CZ), Ospedale Santa Maria (IT), Federico II University Hospital (IT), Azienda USL di Bologna (IT), Istituto Tumori Bari (IT), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), Azienda Ospedaliera Pugliese Ciaccio (IT), Hospital Sírio-Libanês (BR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Ospedaliera Universitaria Pisana (IT), Ospedale di Macerata, University of Florence (IT), University of Macerata (IT), University of Bari Aldo Moro (IT), European Institute of Oncology (IT), Newcastle University (GB), University of Palermo (IT), University of Bologna (IT)
Openalex Percentile: Top 4%
Prostate Cancer Treatment and Research
4.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.